Literature DB >> 22864598

One problem is the risk of the next: a vote for early detection and preventive intervention of coexisting psychopathology.

Aribert Rothenberger.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22864598      PMCID: PMC3411297          DOI: 10.1007/s00787-012-0302-9

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


× No keyword cloud information.
As the readers of this Journal know ECAP and ESCAP (European Society for Child and Adolescent Psychiatry) jointly award the “ECAP-ADHD-Paper of the Year”1 at a European meeting for Child and Adolescent Psychiatry [13]. For the winners of the year 2011, the event chosen was the Eunethydis2 2nd International ADHD Conference in Barcelona (23–25 May, 2012). Two papers out of the 18 published deserved the special attention of the Jury: Imeraj L, Antrop I, Roeyers H, Deschepper E, Bal S, Deboutte D. Diurnal variations in arousal: a naturalistic heart rate study in children with ADHD. Eur Child Adolesc Psychiatry (2011) 20:381–392 Kröger A, Hänig S, Seitz C, Palmason H, Meyer J, Freitag CM. Risk factors of autistic symptoms in children with ADHD. Eur Child Adolesc Psychiatry (2011) 20:561–570 Both studies reported of behavioural risk factors which might trigger problem behaviour in a kind of domino-effect. The work of Imeraj et al. [6] faces two neglected but practically important issues on ADHD, namely, circadiane sleep-wake behaviour and autonomic arousal. Both are basic subcortical functions which may influence higher order cognitive abilities and thus confound many studies on attention in ADHD. The presented data on 24-h heart-rate, reflecting an autonomic imbalance in ADHD, might be considered also in the light of the discussion about cardiovascular side effects of medication in ADHD. Especially, if it is true that already before the long-term use of stimulants, the overall heart-rate levels are increased in children with ADHD (for critical evaluation see also European Guidelines like [1, 5, 15]. Hence, early diagnostics and careful monitoring seems necessary. Kröger et al. [8] focus on the daily clinical issue of differential diagnosis and/or comorbidity of ADHD and increased autistic symptoms. Also, these subclinical symptoms may be confounders in research. Hence, Kröger et al. described risk factors of these increased autistic symptoms in ADHD. Their findings are indicative of possible genetic (maternal autistic traits) as well as environmental factors. The relevance of psychosocial risk factors (e.g. intra-familial discord, abnormal parenting, isolated family) was shown for the first time in this respect and suggests for the future to combine genetic and clinical research more directly in one study, but also to psychosocially support these families very early in their problem solving approaches. Three original articles of this ECAP issue underline the view of clinical risk factors as triggers for further psychopathological signs. For example, children of parents with chronic medical condition displayed a slightly increased risk for internalizing problems [14]. In the Dutch normative sample of the YSR, only 8 % of girls and 9 % of boys were categorized as clinical cases, while in this sample of 160 adolescents 12 % of girls and 11.7 % of boys were found. Although the evaluated anxious/depressed scale of the YSR predicts a DSM-IV disorder only moderately, preventive activities seem to be worthy since ongoing stress and thus chronic elevation of cortisol [3] by thoughts of loss, bereavement and unpredictability of parental health may lead to greater emotional problems. Fortunately, the adolescents of this sample displayed few externalizing problems. Here as well as in the study on ADHD and autism of Kröger et al. [8] the well-known negative impact of psychosocial risks was displayed. On the other hand, there exists evidence that a first psychopathological condition of an individual may form the risk for the appearance and/or severity of a next one. In a large European school survey, based on 45.086 16-year-old adolescents from 16 countries, substance use (tranquillizer, tobacco, alcohol, cannabis) was found as risk factor for self-reported suicide attempts [7]. Remarkably, “the odds ratio of reporting a suicide attempt approximately doubled for every additional substance use”. The authors should be supported when they say, that we, e.g. mental health professionals and public health decision makers, need to shape existing prevention policies. As with most of the adolescents suffering from internalizing problems they are often neglected because of the demanding externalizing problems of their classmates. We need to better listen to the silence. Finally, the complex neuropsychiatric disorder of Tourette syndrome (see also the European Guidelines in this Journal: [2, 10, 12, 16]) reflects some risks within itself, since its comorbidity-profile (especially while changing during the course of illness) makes it a challenging case for the patient and the physician [4, 11, 17]. Lebowitz et al. [9] clarify that chronic tic disorders (CTD) with coexisting obsessive–compulsive disorder is a more severe subtype of CTD, characterized not only by more severe tics but also by e.g. poorer global functioning. Further, similar to the situation of additional substance use [7], Wanderer et al. [17] found in CTD that the presence of comorbid OCD was associated with higher rates of additional comorbid diagnoses; i.e. the earlier the risky obsessive–compulsive traits can be detected in CTD and treated, the better is the precondition for the future course of CTD and patient’s psychosocial functioning/development. In sum, our view on risk factors should not be restricted to environmental or genetic factors. Moreover, the risks within the complex, usually comorbid problem situation of a child psychiatric disorder deserves greater attention in order to prevent exacerbation while detecting and treating the risks quite early in time. In the long run, the effort would be paralleled by a positive cost-benefit-ratio for both, the patients and the society.
  10 in total

1.  Risk factors of autistic symptoms in children with ADHD.

Authors:  Anne Kröger; Susann Hänig; Christiane Seitz; Haukur Palmason; Jobst Meyer; Christine M Freitag
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-10-16       Impact factor: 4.785

Review 2.  Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline.

Authors:  Tobias Banaschewski; David Coghill; Paramala Santosh; Alessandro Zuddas; Philip Asherson; Jan Buitelaar; Marina Danckaerts; Manfred Döpfner; Stephen V Faraone; Aribert Rothenberger; Joseph Sergeant; Hans-Christoph Steinhausen; Edmund J S Sonuga-Barke; Eric Taylor
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-05-05       Impact factor: 4.785

3.  European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions.

Authors:  Cara Verdellen; Jolande van de Griendt; Andreas Hartmann; Tara Murphy
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

4.  European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation.

Authors:  Kirsten R Müller-Vahl; Danielle C Cath; Andrea E Cavanna; Sandra Dehning; Mauro Porta; Mary M Robertson; Veerle Visser-Vandewalle
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

5.  Diurnal variations in arousal: a naturalistic heart rate study in children with ADHD.

Authors:  Lindita Imeraj; Inge Antrop; Herbert Roeyers; Ellen Deschepper; Sarah Bal; Dirk Deboutte
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-05-29       Impact factor: 4.785

6.  European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment.

Authors:  Danielle C Cath; Tammy Hedderly; Andrea G Ludolph; Jeremy S Stern; Tara Murphy; Andreas Hartmann; Virginie Czernecki; Mary May Robertson; Davide Martino; A Munchau; R Rizzo
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

7.  Does the cortisol response to stress mediate the link between expressed emotion and oppositional behavior in Attention-Deficit/Hyperactivity-Disorder (ADHD)?

Authors:  Hanna Christiansen; Robert D Oades; Lamprini Psychogiou; Berthold P Hauffa; Edmund J Sonuga-Barke
Journal:  Behav Brain Funct       Date:  2010-07-15       Impact factor: 3.759

8.  European guidelines on managing adverse effects of medication for ADHD.

Authors:  J Graham; T Banaschewski; J Buitelaar; D Coghill; M Danckaerts; R W Dittmann; M Döpfner; R Hamilton; C Hollis; M Holtmann; M Hulpke-Wette; M Lecendreux; E Rosenthal; A Rothenberger; P Santosh; J Sergeant; E Simonoff; E Sonuga-Barke; I C K Wong; A Zuddas; H-C Steinhausen; E Taylor
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-11-03       Impact factor: 4.785

9.  Supporting researchers: mentoring and awards of the Journal.

Authors:  Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-07       Impact factor: 4.785

10.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.